Tunch Akmandor, Clinical Intern and PhD in Cancer Immunotherapy at Istanbul University-Cerrahpasa, shared a post on LinkedIn:
“Excited to present our poster at ESMO Breast Cancer Congress in Berlin 2026 ESMO Breast 2026.
Paclitaxel-Loaded Silica Nanoparticle Microneedle Arrays Enable Sustained Transdermal Drug Delivery for Localised Breast Cancer Therapy.
A great opportunity to showcase our translational research and engage in inspiring discussions around precision oncology, nanomedicine, targeted drug delivery, and the future of minimally invasive cancer therapeutics.
Grateful to my co-authors Rachel Sully, Hemda Garelick, Erika Loizidou, Adrian Podoleanu and Vladimir Gubala , collaborators, and institution, Middlesex University, University College London Hospitals NHS Foundation Trust, University of Kent, University of Greenwich for their continued support throughout this journey.
Thank you Roche for the morning coffee.”
Other articles about Breast Cancer on OncoDaily.
